{"id":4646,"date":"2023-02-07T11:58:00","date_gmt":"2023-02-07T11:58:00","guid":{"rendered":"https:\/\/www.dsru.org\/?page_id=4646"},"modified":"2023-02-08T10:48:30","modified_gmt":"2023-02-08T10:48:30","slug":"abstracts","status":"publish","type":"page","link":"https:\/\/www.dsru.org\/information-news\/abstracts\/","title":{"rendered":"Abstracts"},"content":{"rendered":"\n<div class=\"course-directory-page-wrapper\">\n        <div class=\"course-directory-page-filter\">\n            <div class=\"product-page-filter filter-nomobile\"><form data-sf-form-id='4645' data-is-rtl='0' data-maintain-state='' data-results-url='https:\/\/www.dsru.org\/information-news\/abstracts\/' data-ajax-url='https:\/\/www.dsru.org\/?sfid=4645&amp;sf_action=get_data&amp;sf_data=all' data-ajax-form-url='https:\/\/www.dsru.org\/?sfid=4645&amp;sf_action=get_data&amp;sf_data=form' data-display-result-method='shortcode' data-use-history-api='1' data-template-loaded='0' data-lang-code='en' data-ajax='1' data-ajax-data-type='json' data-ajax-links-selector='.pagination a' data-ajax-target='#search-filter-results-4645' data-ajax-pagination-type='normal' data-update-ajax-url='1' data-only-results-ajax='1' data-scroll-to-pos='0' data-init-paged='1' data-auto-update='1' data-auto-count='1' data-auto-count-refresh-mode='1' action='https:\/\/www.dsru.org\/information-news\/abstracts\/' method='post' class='searchandfilter' id='search-filter-form-4645' autocomplete='off' data-instance-count='1'><ul><li class=\"sf-field-search\" data-sf-field-name=\"search\" data-sf-field-type=\"search\" data-sf-field-input-type=\"\">\t\t<label>\n\t\t\t\t   <input placeholder=\"Search \u2026\" name=\"_sf_search[]\" class=\"sf-input-text\" type=\"text\" value=\"\" title=\"\"><\/label>\t\t<\/li><li class=\"sf-field-post-meta-year_of_conference\" data-sf-field-name=\"_sfm_year_of_conference\" data-sf-field-type=\"post_meta\" data-sf-field-input-type=\"select\" data-sf-meta-type=\"choice\">\t\t<label>\n\t\t\t\t   \t\t<select name=\"_sfm_year_of_conference[]\" class=\"sf-input-select\" title=\"\">\n\t\t\t\t\t\t  \t\t\t<option class=\"sf-level-0 sf-item-0 sf-option-active\" selected=\"selected\" data-sf-depth=\"0\" value=\"\">Filter by year<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"23\" data-sf-depth=\"0\" value=\"2018\">2018&nbsp;&nbsp;(23)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"7\" data-sf-depth=\"0\" value=\"2019\">2019&nbsp;&nbsp;(7)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select><\/label>\t\t\t\t\t\t\t\t\t\t<\/li><li class=\"sf-field-post-meta-facility_options\" data-sf-field-name=\"_sfm_facility_options\" data-sf-field-type=\"post_meta\" data-sf-field-input-type=\"select\" data-sf-meta-type=\"choice\">\t\t<label>\n\t\t\t\t   \t\t<select name=\"_sfm_facility_options[]\" class=\"sf-input-select\" title=\"\">\n\t\t\t\t\t\t  \t\t\t<option class=\"sf-level-0 sf-item-0 sf-option-active\" selected=\"selected\" data-sf-depth=\"0\" value=\"\">Filter by study type<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"30\" data-sf-depth=\"0\" value=\"CPRD Study\">CPRD Study&nbsp;&nbsp;(30)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"30\" data-sf-depth=\"0\" value=\"Primary Care PASS Study\">Primary Care PASS Study&nbsp;&nbsp;(30)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select><\/label>\t\t\t\t\t\t\t\t\t\t<\/li><li class=\"sf-field-category\" data-sf-field-name=\"_sft_category\" data-sf-field-type=\"category\" data-sf-field-input-type=\"select\" data-sf-term-rewrite='[\"https:\\\/\\\/www.dsru.org\\\/category\\\/[0]\\\/\",\"https:\\\/\\\/www.dsru.org\\\/category\\\/[0]\\\/[1]\\\/\"]'>\t\t<label>\n\t\t\t\t   \t\t<select name=\"_sft_category[]\" class=\"sf-input-select\" title=\"\">\n\t\t\t\t\t\t  \t\t\t<option class=\"sf-level-0 sf-item-0 sf-option-active\" selected=\"selected\" data-sf-count=\"0\" data-sf-depth=\"0\" value=\"\">All Conference Abstracts<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 sf-item-55\" data-sf-count=\"18\" data-sf-depth=\"0\" value=\"icpe\">ICPE&nbsp;&nbsp;(18)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-1 sf-item-44\" data-sf-count=\"7\" data-sf-depth=\"1\" value=\"icpe-philadelphia-august-2019\">&nbsp;&nbsp;&nbsp;ICPE, Philadelphia, August 2019&nbsp;&nbsp;(7)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-1 sf-item-46\" data-sf-count=\"11\" data-sf-depth=\"1\" value=\"icpe-prague-august-2018\">&nbsp;&nbsp;&nbsp;ICPE, Prague, August 2018&nbsp;&nbsp;(11)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 sf-item-54\" data-sf-count=\"13\" data-sf-depth=\"0\" value=\"isop\">ISoP&nbsp;&nbsp;(13)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-1 sf-item-45\" data-sf-count=\"13\" data-sf-depth=\"1\" value=\"isop-18th-annual-meeting-geneva-november-2018\">&nbsp;&nbsp;&nbsp;ISoP, 18th Annual Meeting, Geneva, November 2018&nbsp;&nbsp;(13)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select><\/label>\t\t\t\t\t\t\t\t\t\t<\/li><\/ul><\/form><\/div>\n            <div class=\"filter-yesmobile mob-filter\">\n                <button id=\"show-element\" class=\"filter readon\">Filter<\/button>\n                <div id=\"to-show\" class=\"hide\">\n                    <div class=\"ms-h-filter\"><form data-sf-form-id='4645' data-is-rtl='0' data-maintain-state='' data-results-url='https:\/\/www.dsru.org\/information-news\/abstracts\/' data-ajax-url='https:\/\/www.dsru.org\/?sfid=4645&amp;sf_action=get_data&amp;sf_data=all' data-ajax-form-url='https:\/\/www.dsru.org\/?sfid=4645&amp;sf_action=get_data&amp;sf_data=form' data-display-result-method='shortcode' data-use-history-api='1' data-template-loaded='0' data-lang-code='en' data-ajax='1' data-ajax-data-type='json' data-ajax-links-selector='.pagination a' data-ajax-target='#search-filter-results-4645' data-ajax-pagination-type='normal' data-update-ajax-url='1' data-only-results-ajax='1' data-scroll-to-pos='0' data-init-paged='1' data-auto-update='1' data-auto-count='1' data-auto-count-refresh-mode='1' action='https:\/\/www.dsru.org\/information-news\/abstracts\/' method='post' class='searchandfilter' id='search-filter-form-4645' autocomplete='off' data-instance-count='2'><ul><li class=\"sf-field-search\" data-sf-field-name=\"search\" data-sf-field-type=\"search\" data-sf-field-input-type=\"\">\t\t<label>\n\t\t\t\t   <input placeholder=\"Search \u2026\" name=\"_sf_search[]\" class=\"sf-input-text\" type=\"text\" value=\"\" title=\"\"><\/label>\t\t<\/li><li class=\"sf-field-post-meta-year_of_conference\" data-sf-field-name=\"_sfm_year_of_conference\" data-sf-field-type=\"post_meta\" data-sf-field-input-type=\"select\" data-sf-meta-type=\"choice\">\t\t<label>\n\t\t\t\t   \t\t<select name=\"_sfm_year_of_conference[]\" class=\"sf-input-select\" title=\"\">\n\t\t\t\t\t\t  \t\t\t<option class=\"sf-level-0 sf-item-0 sf-option-active\" selected=\"selected\" data-sf-depth=\"0\" value=\"\">Filter by year<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"23\" data-sf-depth=\"0\" value=\"2018\">2018&nbsp;&nbsp;(23)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"7\" data-sf-depth=\"0\" value=\"2019\">2019&nbsp;&nbsp;(7)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select><\/label>\t\t\t\t\t\t\t\t\t\t<\/li><li class=\"sf-field-post-meta-facility_options\" data-sf-field-name=\"_sfm_facility_options\" data-sf-field-type=\"post_meta\" data-sf-field-input-type=\"select\" data-sf-meta-type=\"choice\">\t\t<label>\n\t\t\t\t   \t\t<select name=\"_sfm_facility_options[]\" class=\"sf-input-select\" title=\"\">\n\t\t\t\t\t\t  \t\t\t<option class=\"sf-level-0 sf-item-0 sf-option-active\" selected=\"selected\" data-sf-depth=\"0\" value=\"\">Filter by study type<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"30\" data-sf-depth=\"0\" value=\"CPRD Study\">CPRD Study&nbsp;&nbsp;(30)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 \" data-sf-count=\"30\" data-sf-depth=\"0\" value=\"Primary Care PASS Study\">Primary Care PASS Study&nbsp;&nbsp;(30)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select><\/label>\t\t\t\t\t\t\t\t\t\t<\/li><li class=\"sf-field-category\" data-sf-field-name=\"_sft_category\" data-sf-field-type=\"category\" data-sf-field-input-type=\"select\" data-sf-term-rewrite='[\"https:\\\/\\\/www.dsru.org\\\/category\\\/[0]\\\/\",\"https:\\\/\\\/www.dsru.org\\\/category\\\/[0]\\\/[1]\\\/\"]'>\t\t<label>\n\t\t\t\t   \t\t<select name=\"_sft_category[]\" class=\"sf-input-select\" title=\"\">\n\t\t\t\t\t\t  \t\t\t<option class=\"sf-level-0 sf-item-0 sf-option-active\" selected=\"selected\" data-sf-count=\"0\" data-sf-depth=\"0\" value=\"\">All Conference Abstracts<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 sf-item-55\" data-sf-count=\"18\" data-sf-depth=\"0\" value=\"icpe\">ICPE&nbsp;&nbsp;(18)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-1 sf-item-44\" data-sf-count=\"7\" data-sf-depth=\"1\" value=\"icpe-philadelphia-august-2019\">&nbsp;&nbsp;&nbsp;ICPE, Philadelphia, August 2019&nbsp;&nbsp;(7)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-1 sf-item-46\" data-sf-count=\"11\" data-sf-depth=\"1\" value=\"icpe-prague-august-2018\">&nbsp;&nbsp;&nbsp;ICPE, Prague, August 2018&nbsp;&nbsp;(11)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-0 sf-item-54\" data-sf-count=\"13\" data-sf-depth=\"0\" value=\"isop\">ISoP&nbsp;&nbsp;(13)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option class=\"sf-level-1 sf-item-45\" data-sf-count=\"13\" data-sf-depth=\"1\" value=\"isop-18th-annual-meeting-geneva-november-2018\">&nbsp;&nbsp;&nbsp;ISoP, 18th Annual Meeting, Geneva, November 2018&nbsp;&nbsp;(13)<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select><\/label>\t\t\t\t\t\t\t\t\t\t<\/li><\/ul><\/form><\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <div class=\"course-directory-page-results\"><div class=\"search-filter-results\" id=\"search-filter-results-4645\">    \n\n\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 270: Distribution of CHA2DS2-VASc Scores in Patients with Atrial Fibrillation Treated with Rivaroxaban in Primary vs. Secondary Care Settings<\/h2>\n\t\t\t\t <p>Since its incorporation in the European Society of Cardiology guidelines in 2010, the CHA2DS2-VASc score is widely used to characterise the risk of stroke in patients (pts) with atrial fibrillation (AF).<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-270-distribution-of-cha2ds2-vasc-scores-in-patients-with-atrial-fibrillation-treated-with-rivaroxaban-in-primary-vs-secondary-care-settings\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 269: Assessment of Start Dose in Patients Prescribed Rivaroxaban for Atrial Fibrillation with Chronic Kidney Disease-Results from the ROSE Study<\/h2>\n\t\t\t\t <p>Rivaroxaban is used to treat patients with non-valvular AF for the prevention of stroke and systemic embolism. <\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-269-assessment-of-start-dose-in-patients-prescribed-rivaroxaban-for-atrial-fibrillation-with-chronic-kidney-disease-results-from-the-rose-study\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 268: Characteristics of Patients Started on a Reduced Dose of Rivaroxaban for Atrial Fibrillation \u2013 Results from the ROSE Study<\/h2>\n\t\t\t\t <p>Rivaroxaban is used to treat a range of conditions, including prevention of stroke and systemic embolism in patients with AF. <\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-268-characteristics-of-patients-started-on-a-reduced-dose-of-rivaroxaban-for-atrial-fibrillation-results-from-the-rose-study\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 267: Incidence Of Major And Clinically-Relevant Non-Major Bleeding In Patients Prescribed Rivaroxaban: Results From The ROSE Study<\/h2>\n\t\t\t\t <p>The ROSE (Rivaroxaban Observational Safety Evaluation) Specialist Cohort Event Monitoring (SCEM) study was conducted to monitor the safety and use of rivaroxaban for Stroke Prevention in patients (pts) with non-valvular AF (SPAF) and the prevention and\/or treatment of Deep Vein Thrombosis and\/or Pulmonary Embolism (DVT\/PE) in the secondary care setting in England and Wales. <\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-267-incidence-of-major-and-clinically-relevant-non-major-bleeding-in-patients-prescribed-rivaroxaban-results-from-the-rose-study\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 266: Multi-Level Modelling To Investigate Factors Impacting Prescribing Variability<\/h2>\n\t\t\t\t <p>Prescribing guidelines influence treatment choice based on patient and healthcare system factors.<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-266-multi-level-modelling-to-investigate-factors-impacting-prescribing-variability\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 265: Risk Of Major And Clinically Relevant Non-Major (CRNM) Bleeding In Patients Prescribed Rivaroxaban In Primary Care In England<\/h2>\n\t\t\t\t <p>Clinical trials and observational studies have reported bleeding risk in patients taking rivaroxaban.<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-265-risk-of-major-and-clinically-relevant-non-major-crnm-bleeding-in-patients-prescribed-rivaroxaban-in-primary-care-in-england\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 264: Utilisation and safety of asenapine in secondary care in the UK: Results from the Observational Safety Evaluation of Asenapine (OBSERVA) study<\/h2>\n\t\t\t\t <p>The OBSERVA specialist cohort event monitoring (SCEM) study, conducted in secondary care in the UK, formed part of an EU risk management plan to monitor the use and short-term safety of asenapine, licensed for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults.<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-264-utilisation-and-safety-of-asenapine-in-secondary-care-in-the-uk-results-from-the-observational-safety-evaluation-of-asenapine-observa-study\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 263: Utilisation and Safety of Asenapine in Primary Care in England: Results from a PASS<\/h2>\n\t\t\t\t <p>Asenapine is approved in the EU for the treatment of manic episodes associated with bipolar I disorder in adults.<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-263-utilisation-and-safety-of-asenapine-in-primary-care-in-england-results-from-a-pass\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 262: Passive Enhanced Safety Surveillance In Children Receiving Fluenz\u00ae Tetra Vaccination In England During The Early 2017-2018 Influenza Season.<\/h2>\n\t\t\t\t <p>Fluenz\u00ae Tetra is a quadrivalent, live attenuated, intranasal, influenza vaccine recommended for use in children aged 2 to 17 years vaccinated as part of the seasonal influenza immunisation campaign in the UK.<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-262-passive-enhanced-safety-surveillance-in-children-receiving-fluenz-tetra-vaccination-in-england-during-the-early-2017-2018-influenza-season\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"course-page-tile\">\n\t\t\t<div class=\"course-page-tile-title\">\n\t\t\t\t<div class=\"abstractsTags\">\n\t\t\t<ul class=\"post-categories\">\n\t<li><a href=\"https:\/\/www.dsru.org\/category\/isop\/isop-18th-annual-meeting-geneva-november-2018\/\" rel=\"category tag\">ISoP, 18th Annual Meeting, Geneva, November 2018<\/a><\/li><\/ul>\t\t\t<p><span>CPRD Study<\/span><span>Primary Care PASS Study<\/span><\/p>\n<\/div>\n                <h2>Abstract 271: Impact analyses of EU pharmacovigilance interventions on public health burden<\/h2>\n\t\t\t\t <p>Adverse drug reactions (ADRs) account for 5% hospital admissions and 197,000 deaths each year, amounting to a societal cost of \u20ac79billion.<\/p>\n            <\/div>\n            <div class=\"course-page-tile-block\">\n                <a class=\"readon\" href=\"https:\/\/www.dsru.org\/abstract\/abstract-271-impact-analyses-of-eu-pharmacovigilance-interventions-on-public-health-burden\/\">View Abstract<\/a>\n            <\/div>\n\t\t<\/div>\n\t\t\n\t\n<\/div><\/div>\n    <\/div>\n    <script src=\"https:\/\/dolia.co.uk\/wp-content\/themes\/dolia\/js\/shreveal.js\"><\/script>\n","protected":false},"excerpt":{"rendered":"<p>Filter<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":22,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-directory.php","meta":{"_acf_changed":false,"footnotes":""},"coauthors":[29],"class_list":["post-4646","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Abstracts - DSRU<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dsru.org\/information-news\/abstracts\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abstracts - DSRU\" \/>\n<meta property=\"og:description\" content=\"Filter\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dsru.org\/information-news\/abstracts\/\" \/>\n<meta property=\"og:site_name\" content=\"DSRU\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DrugSafetyResearchUnit\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-08T10:48:30+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@DSRUDrugSafety\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ashleigh barton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/abstracts\\\/\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/abstracts\\\/\",\"name\":\"Abstracts - DSRU\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#website\"},\"datePublished\":\"2023-02-07T11:58:00+00:00\",\"dateModified\":\"2023-02-08T10:48:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/abstracts\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/abstracts\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/abstracts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.dsru.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Information &#038; News\",\"item\":\"https:\\\/\\\/www.dsru.org\\\/information-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Abstracts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#website\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/\",\"name\":\"DSRU\",\"description\":\"The UK\u2019s leading pharmacovigilance and pharmacoepidemiology unit.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#organization\"},\"alternateName\":\"Drug Safety Research Unit\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dsru.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#organization\",\"name\":\"DSRU\",\"alternateName\":\"Drug Safety Research Unit\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.dsru.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cropped-DSRU_Branding.png\",\"contentUrl\":\"https:\\\/\\\/www.dsru.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/cropped-DSRU_Branding.png\",\"width\":250,\"height\":115,\"caption\":\"DSRU\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dsru.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/DrugSafetyResearchUnit\",\"https:\\\/\\\/x.com\\\/DSRUDrugSafety\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/drug-safety-research-unit\\\/\",\"https:\\\/\\\/www.instagram.com\\\/drugsafetyresearchunit\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abstracts - DSRU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dsru.org\/information-news\/abstracts\/","og_locale":"en_GB","og_type":"article","og_title":"Abstracts - DSRU","og_description":"Filter","og_url":"https:\/\/www.dsru.org\/information-news\/abstracts\/","og_site_name":"DSRU","article_publisher":"https:\/\/www.facebook.com\/DrugSafetyResearchUnit","article_modified_time":"2023-02-08T10:48:30+00:00","twitter_card":"summary_large_image","twitter_site":"@DSRUDrugSafety","twitter_misc":{"Written by":"ashleigh barton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.dsru.org\/information-news\/abstracts\/","url":"https:\/\/www.dsru.org\/information-news\/abstracts\/","name":"Abstracts - DSRU","isPartOf":{"@id":"https:\/\/www.dsru.org\/#website"},"datePublished":"2023-02-07T11:58:00+00:00","dateModified":"2023-02-08T10:48:30+00:00","breadcrumb":{"@id":"https:\/\/www.dsru.org\/information-news\/abstracts\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dsru.org\/information-news\/abstracts\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.dsru.org\/information-news\/abstracts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dsru.org\/"},{"@type":"ListItem","position":2,"name":"Information &#038; News","item":"https:\/\/www.dsru.org\/information-news\/"},{"@type":"ListItem","position":3,"name":"Abstracts"}]},{"@type":"WebSite","@id":"https:\/\/www.dsru.org\/#website","url":"https:\/\/www.dsru.org\/","name":"DSRU","description":"The UK\u2019s leading pharmacovigilance and pharmacoepidemiology unit.","publisher":{"@id":"https:\/\/www.dsru.org\/#organization"},"alternateName":"Drug Safety Research Unit","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dsru.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.dsru.org\/#organization","name":"DSRU","alternateName":"Drug Safety Research Unit","url":"https:\/\/www.dsru.org\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.dsru.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.dsru.org\/wp-content\/uploads\/2022\/01\/cropped-DSRU_Branding.png","contentUrl":"https:\/\/www.dsru.org\/wp-content\/uploads\/2022\/01\/cropped-DSRU_Branding.png","width":250,"height":115,"caption":"DSRU"},"image":{"@id":"https:\/\/www.dsru.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/DrugSafetyResearchUnit","https:\/\/x.com\/DSRUDrugSafety","https:\/\/www.linkedin.com\/company\/drug-safety-research-unit\/","https:\/\/www.instagram.com\/drugsafetyresearchunit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/4646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/comments?post=4646"}],"version-history":[{"count":6,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/4646\/revisions"}],"predecessor-version":[{"id":4663,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/4646\/revisions\/4663"}],"up":[{"embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/pages\/22"}],"wp:attachment":[{"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/media?parent=4646"}],"wp:term":[{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.dsru.org\/wp-json\/wp\/v2\/coauthors?post=4646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}